Volume 22, Issue 2 (Jun _ Jul 2018)                   2018, 22(2): 48-62 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Seirafi M, Namjoo S, Sabet M. Efficacy of cognitive-behavioral therapy for adherence, depression and negative illness representations in rheumatoid arthritis patients: A randomized controlled trial. Journal of Inflammatory Diseases. 2018; 22 (2) :48-62
URL: http://journal.qums.ac.ir/article-1-2521-en.html
1- Department of Health Psychology, Islamic Azad University, Alborz, Iran
2- Department of Health Psychology, Islamic Azad University, Alborz, Iran , namjoopsy@gmail.com
3- Department of Psychometrics and Quantitative Psychology, Department of Psychology, Islamic Azad University, Roudehen, Iran
Abstract:   (5862 Views)
Background: Rheumatoid arthritis (RA) is a chronic inflammatory polyarthritis with multiple clinical symptoms and psychological problems, such as depression. Psychotherapy can play an important role in achieving therapeutic goals.
Objective: The purpose of this study was to determine the effect of cognitive behavioral therapy for adherence, depression (CBT-AD) and negative illness representations in people with RA.
Methods: A clinical trial was conducted in Rheumatology’s clinic in a Shariaty hospital in Tehran during 2016-2017, Iran. Then, among 151 patients with rheumatoid arthritis, 28 patient were selected using the sampling judgment and half of them were randomly assigned to the CBT-AD (14 patients) and the others were in the control group (14 patients). 
Psychological questionnaires including the illness perception questionnaire-revised, beck depression inventory and general adherence Scale were measured. All data were analyzed by independent t-test, Chi-square and multivariate covariance analysis.
Findings: The results showed that the baseline, post-test score between two intervention and control groups in three dimensions of illness representations (P<0.001), depression (P<0.001) and adherence (P<0.001) were statistically significant.
Conclusion: CBT-AD is a potentially efficacious approach for individuals with RA struggling with depression at the same time, which leads to a reduction in depression, an increase in adherence and correction of negative illness representations.
Full-Text [PDF 249 kb]   (1615 Downloads)    
Type of Study: Clinical trial | Subject: Psychiatry

1. Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014; 73(7): 1316-22. [DOI] [PubMed]
2. Askary-Ashtiani AR, Mousavi SJ, Montazeri A, Shamsollahi S, Parnianpour M. Cultural adaptation and validation of the Persian version of the arthritis impact measurement scales 2-short form in patients with osteoarthritis of the knee. Disabil Rehabil 2009; 31(25): 2081-7. doi: 10.3109/ 09638280902918746. [PubMed]
3. Blum MA, Koo D, Doshi JA. Measurement and rates of persistence with and adherence to biologics for rheumatoid arthritis: a systematic review. Clin Ther 2011; 33(7): 901-13. [DOI] [PubMed]
4. Brus H, van de Laar M, Taal E, Rasker J, Wiegman O. Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient Educ Couns 1999; 36(1): 57-64. [DOI] [PubMed]
5. Doyle DV, Perrett D, Foster OJ, Ensor M, Scott DL. The long-term use of D-penicillamine for treating rheumatoid arthritis: is continuous therapy necessary? Br J Rheumatol 1993; 32(7): 614-7. [DOI] [PubMed]
6. Koncz T, Pentek M, Brodszky V, Ersek K, Orlewska E, Gulacsi L. Adherence to biologic DMARD therapies in rheumatoid arthritis. Expert Opin Biol Ther 2010; 10(9): 1367-78. [DOI] [PubMed]
7. Pullar T, Peaker S, Martin MF, Bird HA, Feely MP. The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy. Br J Rheumatol 1988; 27(5): 381-4. [DOI] [PubMed]
8. Contreras-Yá-ez I, Ponce De León S, Cabiedes J, Rull-Gabayet M, Pascual-Ramos V. Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs. Am J Med Sci 2010; 340(4): 282-90. doi: 10.1097/ MAJ.0b013e3181e8bcb0. [PubMed]
9. Van den Bemt BJf. Optimizing pharmacotherapy in patients with rheumatoid arthritis: an individualized approach: [Sl: sn]; 2009.68-83.
10. Viller F, Guillemin F, Briancon S, Moum T, Suurmeijer T, van den Heuvel W. Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol 1999; 26(10): 2114-22. [PubMed]
11. Englbrecht M, Alten R, Aringer M, Baerwald C, Burkhardt H, Eby N, et al. FRI0142 High prevalence of depression in patients with rheumatoid arthritis-Data from the large cross-sectional Vadera II study. Ann Rheum Dis 2016; 75(Suppl 2): 2-80. [DOI]
12. Margaretten M, Julian L, Katz P, Yelin E. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumatol 2011; 6(6): 617-23. doi: 10. 2217/IJR.11.6 [PubMed]
13. Brandstetter S, Riedelbeck G, Steinmann M, Loss J, Ehrenstein B, Apfelbacher C. Depression moderates the associations between beliefs about medicines and medication adherence in patients with rheumatoid arthritis: cross-sectional study. J Health Psychol 2016: 1359105316646440. [DOI] [PubMed]
14. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res 2002; 53(4): 859-63. [DOI] [PubMed]
15. Rathbun AM, Reed GW, Harrold LR. The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review. Rheumatology (Oxford) 2013; 52(10): 1785-94. [DOI] [PubMed]
16. Joyce AT, Smith P, Khandker R, Melin JM, Singh A. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. J Rheumatol 2009; 36(4): 743-52. [DOI] [PubMed]
17. Gonzalez JS, Penedo FJ, Llabre MM, Durán RE, Antoni MH, Schneiderman N, et al. Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann Behav Med 2007; 34(1): 46-55. [DOI] [PubMed]
18. Covic T, Tyson G, Spencer D, Howe G. Depression in rheumatoid arthritis patients: demographic, clinical, and psychological predictors. J Psychosom Res 2006; 60(5): 469-76. [DOI] [PubMed]
19. Reach G. The mental mechanisms of patient adherence to long-term therapies. mind and care. 2nd ed. New York: Springer Press; 2015; 128-37.
20. Hale ED, Treharne GJ, Kitas GD. The Common-Sense Model of self-regulation of health and illness: how can we use it to understand and respond to our patients' needs? Rheumatology (Oxford) 2007; 46(6): 904-6. [DOI] [PubMed]
21. Safren S, Gonzalez J, Soroudi N. Coping with chronic illness. A cognitive-behavioral therapy approach for adherence and depression. 1st ed. New York: Oxford University Press; 2007; 87-90.
22. Safren SA, Hendriksen ES, Mayer KH, Mimiaga MJ, Pickard R, Otto MW. Cognitive-behavioral therapy for HIV medication adherence and depression. Cogn Behav Pract 2004; 11(4): 415-24. [DOI]
23. Haghighi TH, Dousty Y, Mirzaian B, Kazem FM. Effectiveness of group cognitive-behavioral therapy on illness perception, pain perception and life quality in patients with rheumatoid arthritis. Scientific J Kurdistan Univ Med Sci 2015;20(3): 45-57 [In Persian].
24. Leventhal H, Leventhal EA, Contrada RJ. Self-regulation, health, and behavior: a perceptual-cognitive approach. Psychol Health 1998; 13(4): 717-33. [DOI]
25. Groarke A, Curtis R, Coughlan R, Gsel A. The impact of illness representations and disease activity on adjustment in women with rheumatoid arthritis: a longitudinal study. Psychol Health 2005; 20(5): 597-613. [DOI]
26. Ferguson A, Ibrahim FA, Thomas V, Weinman J, Simpson C, Cope AP, et al. Improving medication adherence in rheumatoid arthritis (RA): a pilot study. Psychol Health Med 2015; 20(7): 781-9. [DOI] [PubMed]
27. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310(20):2191-4. [DOI] [PubMed]
28. Kay J, Upchurch KS. ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology 2012; 51(suppl_6): vi5-9. doi: 10.1093/rheumatology.2012.kes279. [PubMed]
29. Little RJ, D'agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med 2012; 367(14): 1355-60. doi: 10.1056/ NEJMsr 1203730.
30. Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron LD, Buick D. The revised illness perception questionnaire (IPQ-R). Psychol Health 2002; 17(1): 1-16. [DOI]
31. Ghasemzadeh H, Arjmand M, Mohsenifar S, Hamidpour H. The revised illness perception questionnaire. Available from: https://www.uib.no/ipq/index.html (accessed 10 Oct 2007).
32. Hazhir F, Ahadi H, Pourshahbaz A, Rezaei M. The effectiveness of cognitive-behavior therapy on illness representations of multiple-sclerosis and improving their emotional states. J Kermanshah Univ Med Sci 2012; 15(6): 415-26. [In Persian]
33. Rajabi G, Karjo KS. Psychometric properties of a persian-language version of the Beck depression inventory–second edition (BDI-II-persian). Traning Measurement 2013; 3(10): 139-57. [In Persian]
34. Arjmandnia A, Namjoo S. Efficacy of memory specificity training (MEST) on underlying mechanisms of over general autobiographical memory (OGM) in people with major depression and childhood traumatic experience. J Isfahan Med Sch 2015; 33(329): 442-56. [In Persian]
35. Hays RD. The Medical Outcomes Study (MOS) measures of patient adherence. 2nd ed. Oxford: Blackwell Science; 1994. 505-17.
36. Zarani F, Besharat MA, Sarami G, Sadeghian S. An information–motivation–behavioral skills (IMB) model-based intervention for CABG patients. Int J Behav Med 2012; 19(4): 543-9. doi: 10.1177/ 1359105309357092. [PubMed]
37. Fransen J, Stucki G, van Riel PL. Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score‐28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI). Arthritis Care Res 2003; 49(S5): S214-S224. [DOI]
38. Morowatisharifabad M, Nadrian H, Soleimani Salehabadi H, Mazloomy Mahmoodabad S, Asgarshahi M. The relationship between predisposing factors and self-care behaviors among patients with rheumatoid arthritis. Hayat 2009; 15(3): 39-51. [In Persian]
39. Nazemi Ardakani F, Bahrami H, Alipor A, Bayat N. Effectiveness of religious - spiritual intervention based on Islamic approach on psychological and immune indices in patients with Rheumatoid Arthritis. J Psycholl Res Quarterly 2016; 6(4): 113-31. [In Persian]
40. Nazemi Ardakani F, Bahrami H. Effectiveness of cognitive behavioral stress management intervention on psychological and immune factors in patients with Rheumatoid Arthritis referred to the rheumatology clinics of Baghiat Allah hospital. J Military Psychology 2015; 6(22): 55-6. [In Persian]
41. Zwikker HE, van den Ende CH, van Lankveld WG, den Broeder AA, van den Hoogen FH, van de Mosselaar B, et al. Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: a randomized controlled trial. Patient Educ Couns 2014; 94(3): 356-61. [DOI] [PubMed]
42. Goodman D, Morrissey S, Graham D, Bossingham D. The application of cognitive-behaviour therapy in altering illness representations of systemic lupus erythematosus. Behav Change 2005; 22(3): 15 6-71. [DOI]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Inflammatory Diseases

Designed & Developed by : Yektaweb